ARCHIVES

Also R01 payline likely to fall below 20th percentile in FY04.

This article is from The Cancer Letter archive.

Vol. 29 No. 35 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program

April 17, 1981